Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

  1. Powles, T.
  2. Durán, I.
  3. van der Heijden, M.S.
  4. Loriot, Y.
  5. Vogelzang, N.J.
  6. De Giorgi, U.
  7. Oudard, S.
  8. Retz, M.M.
  9. Castellano, D.
  10. Bamias, A.
  11. Fléchon, A.
  12. Gravis, G.
  13. Hussain, S.
  14. Takano, T.
  15. Leng, N.
  16. Kadel, E.E.
  17. Banchereau, R.
  18. Hegde, P.S.
  19. Mariathasan, S.
  20. Cui, N.
  21. Shen, X.
  22. Derleth, C.L.
  23. Green, M.C.
  24. Ravaud, A.
Aldizkaria:
The Lancet

ISSN: 1474-547X 0140-6736

Argitalpen urtea: 2018

Alea: 391

Zenbakia: 10122

Orrialdeak: 748-757

Mota: Artikulua

DOI: 10.1016/S0140-6736(17)33297-X GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak